Innova Captab Limited Market Cap ($634.52 Million)
Market Cap & Net Worth: Innova Captab Limited (INNOVACAP)
Innova Captab Limited market cap. Innova Captab Limited (NSE:INNOVACAP) has a market capitalization of $634.52 Million (Rs58.67 Billion) as of November 1, 2026. Listed on the NSE stock exchange, this India-based company holds position #10667 globally and #530 in its home market, demonstrating a 2.89% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Innova Captab Limited's stock price Rs1025.30 by its total outstanding shares 57224929 (57.22 Million). Also see INNOVACAP operating cash flow for how efficiently the company converts equity into cash flow.
Innova Captab Limited Market Cap History (2023–2026)
Innova Captab Limited market cap history from 2023 to 2026. Data shows growth from $335.05 Million to $634.52 Million (25.23% CAGR). Check latest Innova Captab Limited stock price today for real-time trading data and today's change.
Innova Captab Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Innova Captab Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Innova Captab Limited to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.04x
Innova Captab Limited's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.45x
Innova Captab Limited's market cap is 0.45 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $335.05 Million | $9.26 Billion | $679.54 Million | 0.04x | 0.49x |
| 2024 | $690.28 Million | $10.77 Billion | $943.45 Million | 0.06x | 0.73x |
| 2025 | $445.65 Million | $12.44 Billion | $1.28 Billion | 0.04x | 0.35x |
| 2026 | $634.52 Million | $16.04 Billion | $1.41 Billion | 0.04x | 0.45x |
Competitor Companies of INNOVACAP by Market Capitalization
Companies near Innova Captab Limited in the global market cap rankings as of November 1, 2026. Also see balance sheet size of Innova Captab Limited for a full breakdown of the balance sheet.
Key companies related to Innova Captab Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Innova Captab Limited (2023–2026)
Market capitalization of Innova Captab Limited from 2023 to today. Between 2023 and today, Innova Captab Limited's market cap moved from $335.05 Million to $ 634.52 Million, with a yearly change of 25.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs634.52 Million | +42.38% |
| 2025 | Rs445.65 Million | -35.44% |
| 2024 | Rs690.28 Million | +106.02% |
| 2023 | Rs335.05 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Innova Captab Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $634.52 Million USD |
| MoneyControl | $634.52 Million USD |
| MarketWatch | $634.52 Million USD |
| marketcap.company | $634.52 Million USD |
| Reuters | $634.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Innova Captab Limited
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cepha… Read more